Mechanism of Metastasis is Discovered in Pancreatic Cancer
The Foundation’s dedicated lab at Cold Spring Harbor Laboratory (CSHL) used organoid technology to find that pancreatic cancer cells reprogram…
Discovery of Distinct Cell Subtypes Around Tumors Helps Explain Why Pancreatic Cancer is so Hard to Treat
With a median survival of only 6 months and a 5-year survival rate of about 8%, patients tend to be…
Dr. David Tuveson named Director, NCI-Designated Cancer Center at Cold Spring Harbor Laboratory
Dr. Stillman has served as director of the Laboratory’s National Cancer Institute (NCI)-designated Cancer Center for 25 years, shepherding the…
Currently in the Fight, at Memorial Sloan Kettering Cancer Center
A woman’s treatment for non-operable pancreatic cancer at Memorial Sloan Kettering includes FOLFIRINOX and stereotactic body radiation therapy.
Novel Drug Therapy Kills Pancreatic Cancer Cells by Reducing Levels of Antioxidants
New research finds that reducing antioxidants can help kill pancreatic cancer cells, suggesting a new direction for treatment.